RING
LIVE

Serial Number

98157840

Owner

RING THERAPEUTICS, INC.

Attorney

Christina M. Licursi

First Use Date

Sep 16, 2024

Filing Date

Aug 30, 2023

Add to watchlist:

No watchlists yet
View on USPTO

RING Trademark

Serial Number: 98157840

RING is a trademark filed by RING THERAPEUTICS, INC. on August 30, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

RING THERAPEUTICS, INC. (19 trademarks)

CAMBRIDGE, MA 02142

Entity Type: 03

Trademark Details

Filing Date

August 30, 2023

Registration Date

Not Registered

First Use Anywhere

September 16, 2024

First Use in Commerce

September 16, 2024

Published for Opposition

January 2, 2024

Goods & Services

Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in gene therapy

Filing History

STATEMENT OF USE PROCESSING COMPLETE
Jan 4, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 4, 2025 AITU
USE AMENDMENT FILED
Oct 17, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 17, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 27, 2024 EXRA
SOU EXTENSION 1 GRANTED
Aug 27, 2024 EX1G
SOU EXTENSION 1 FILED
Aug 27, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 27, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 27, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 2, 2024 PUBO
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 26, 2023 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 26, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 26, 2023 COAR
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 13, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 29, 2023 CNSA
ASSIGNED TO EXAMINER
Nov 28, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 27, 2023 NWOS
NEW APPLICATION ENTERED
Sep 2, 2023 NWAP